Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrahas Koumar Ratnacaram

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Oncology (Northwood, London, England)|February 28, 2025
Targeting the TGF-β-p21 axis: a critical regulator of bleomycin-induced cell cycle arrest and apoptosis in vitro-implication for progressive cervical cancer therapySomi Shrivastava, Chandrahas Koumar Ratnacaram
Results and Problems in Cell Differentiation|June 2, 2011
Established and novel Cdk/cyclin complexes regulating the cell cycle and developmentLakshmi Gopinathan, Chandrahas Koumar Ratnacaram, Philipp Kaldis
Molecular Biology Reports|September 17, 2023
Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinomaAsrarunissa Kalmatte, Punchappady Devasya Rekha, Chandrahas Koumar Ratnacaram
Frontiers in Bioscience (Scholar Edition)|December 8, 2021
Repertoires of MicroRNA-30 family as gate-keepers in lung cancerShruthi Kanthaje, Nandakishore Baikunje, Irfan Kandal, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 13, 2022
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancerRenjith P Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, et al.
International Review of Cell and Molecular Biology|February 12, 2025
Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancerSabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2022
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosisSabareeswaran Krishnan, Shruthi Kanthaje, Devasya Rekha Punchappady, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinomaChandrahas Koumar Ratnacaram, Marius Teletin, Ming Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regenerationM Kasim Diril, Chandrahas Koumar Ratnacaram, V C Padmakumar, et al.
The Biochemical Journal|July 3, 2016
Cdk2 catalytic activity is essential for meiotic cell division in vivoSangeeta Chauhan, M Kasim Diril, Joanna H S Lee, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|February 28, 2025
Targeting the TGF-β-p21 axis: a critical regulator of bleomycin-induced cell cycle arrest and apoptosis in vitro-implication for progressive cervical cancer therapySomi Shrivastava, Chandrahas Koumar Ratnacaram
Results and Problems in Cell Differentiation|June 2, 2011
Established and novel Cdk/cyclin complexes regulating the cell cycle and developmentLakshmi Gopinathan, Chandrahas Koumar Ratnacaram, Philipp Kaldis
Molecular Biology Reports|September 17, 2023
Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinomaAsrarunissa Kalmatte, Punchappady Devasya Rekha, Chandrahas Koumar Ratnacaram
Frontiers in Bioscience (Scholar Edition)|December 8, 2021
Repertoires of MicroRNA-30 family as gate-keepers in lung cancerShruthi Kanthaje, Nandakishore Baikunje, Irfan Kandal, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 13, 2022
Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancerRenjith P Johnson, Chandrahas Koumar Ratnacaram, Lalit Kumar, et al.
International Review of Cell and Molecular Biology|February 12, 2025
Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancerSabareeswaran Krishnan, Shruthi Kanthaje, Punchappady Devasya Rekha, et al.
Journal of Cancer Research and Clinical Oncology|June 28, 2022
Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosisSabareeswaran Krishnan, Shruthi Kanthaje, Devasya Rekha Punchappady, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2008
Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinomaChandrahas Koumar Ratnacaram, Marius Teletin, Ming Jiang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regenerationM Kasim Diril, Chandrahas Koumar Ratnacaram, V C Padmakumar, et al.
The Biochemical Journal|July 3, 2016
Cdk2 catalytic activity is essential for meiotic cell division in vivoSangeeta Chauhan, M Kasim Diril, Joanna H S Lee, et al.
Pageof 2